Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Establishing Mouse Models of B-Cell Non-Hodgkin's Lymphoma

Weili Xue, Weiming Li, Yanjie Zhang, Yue Song, Xuan Lan, Zhaoming Li, MDPhD, Xudong Zhang, MDPhD, Ken H. Young, MD PhD, Mingzhi Zhang, Xiaoyan Feng, Guannan Wang, Zhiyuan Zhou, MD PhD, Lisha Lu, Yingjun Wang, PhD, Mengyuan Jin

Blood (2017) 130 (Supplement 1): 5149.

https://doi.org/10.1182/blood.V130.Suppl_1.5149.5149

Published: 2017

Journal Articles

Clinical and Molecular Significance of Peripheral Blood Cell-Free DNA in B-Cell Lymphomas for Detection of Genetic Mutations and Correlation with Disease Status

Yasuhiro Suzuki, MD, Akihiro Tomita, MD PhD, Kenichi Yoshida, MD PhD, Kazuyuki Shimada, MD PhD, Chisako Iriyama, MD PhD, Masashi Sanada, MD PhD, Yuichi Shiraishi, PhD, Kenichi Chiba, PhD, Hiroko Tanaka, BA, Satoru Miyano, PhD, Seishi Ogawa, MD PhD, Hitoshi Kiyoi, MD PhD

Blood (2014) 124 (21): 1658.

https://doi.org/10.1182/blood.V124.21.1658.1658

Published: 2014

Journal Articles

Initial Experience with Rituximab and 90Y-Ibritumomab Tiuxetan for the Treatment of Mature B-Cell Lymphoma.

Salem H. AI-Shemmari, MD, Shihab M. Al-Mohannadi, MD, Haider A. Khan, MD, Kamlesh P. Sajnani, MD

Blood (2006) 108 (11): 4734.

https://doi.org/10.1182/blood.V108.11.4734.4734

Published: 2006

Journal Articles

Clinical Features and Prognostic Assessment of Nodal Marginal Zone B-Cell Lymphoma, a Rare Disease with Follicular-Like Behaviour.

Luca Arcaini, Marco Paulli, Sara Burcheri, Emanuela Boveri, Andrea Rossi, Michele Spina, Francesco Passamonti, Mauro Montanari, Andrea Gallamini, Lilj Uziel, Monica Crugnola, Francesca Montanari, Cristiana Pascutto, Enrica Morra, Mario Lazzarino

Blood (2006) 108 (11): 2427.

https://doi.org/10.1182/blood.V108.11.2427.2427

Published: 2006

Journal Articles

A Phase II Clinical Study of Rituximab and High-Dose Biweekly THP-COP (Pirarubicin, Cyclophosphamide, Vincristine and Predonisolone) with G-CSF for Non-Hodgkin Lymphoma: Results of a Multicentric Study of NMLSG (Niigata Malignant Lymphoma Study Group).

Jun Takizawa, MD, PhD, Sadao Aoki, MD, PhD, Kazue Takai, MD, Tohri Kurasaki, MD, Keiichiro Honma, MD, Masutaka Higashimura, MD, Kouichi Nagai, MD, Akihito Momoi, MD, PhD, Koji Nikkuni, MD, PhD, Yoshufusa Aizawa, MD

Blood (2005) 106 (11): 4734.

https://doi.org/10.1182/blood.V106.11.4734.4734

Published: 2005

Journal Articles

Nodal marginal zone B-cell lymphomas may arise from different subsets of marginal zone B lymphocytes

Annarita Conconi, Francesco Bertoni, Ennio Pedrinis, Teresio Motta, Enrico Roggero, Stefano Luminari, Carlo Capella, Marzia Bonato, Franco Cavalli, Emanuele Zucca

Blood (2001) 98 (3): 781–786.

https://doi.org/10.1182/blood.V98.3.781

Published: 2001

NARROW

Establishing Mouse Models of B-Cell Non-Hodgkin's Lymphoma

Clinical and Molecular Significance of Peripheral Blood Cell-Free DNA in B-Cell Lymphomas for Detection of Genetic Mutations and Correlation with Disease Status

Initial Experience with Rituximab and 90Y-Ibritumomab Tiuxetan for the Treatment of Mature B-Cell Lymphoma.

Clinical Features and Prognostic Assessment of Nodal Marginal Zone B-Cell Lymphoma, a Rare Disease with Follicular-Like Behaviour.

A Phase II Clinical Study of Rituximab and High-Dose Biweekly THP-COP (Pirarubicin, Cyclophosphamide, Vincristine and Predonisolone) with G-CSF for Non-Hodgkin Lymphoma: Results of a Multicentric Study of NMLSG (Niigata Malignant Lymphoma Study Group).

Nodal marginal zone B-cell lymphomas may arise from different subsets of marginal zone B lymphocytes

Email alerts

ASH Publications

American Society of Hematology

Establishing Mouse Models of B-Cell Non-Hodgkin's Lymphoma

Clinical and Molecular Significance of Peripheral Blood Cell-Free DNA in B-Cell Lymphomas for Detection of Genetic Mutations and Correlation with Disease Status

Initial Experience with Rituximab and 90Y-Ibritumomab Tiuxetan for the Treatment of Mature B-Cell Lymphoma.

Clinical Features and Prognostic Assessment of Nodal Marginal Zone B-Cell Lymphoma, a Rare Disease with Follicular-Like Behaviour.

A Phase II Clinical Study of Rituximab and High-Dose Biweekly THP-COP (Pirarubicin, Cyclophosphamide, Vincristine and Predonisolone) with G-CSF for Non-Hodgkin Lymphoma: Results of a Multicentric Study of NMLSG (Niigata Malignant Lymphoma Study Group).

Nodal marginal zone B-cell lymphomas may arise from different subsets of marginal zone B lymphocytes

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only